Principal Financial Group Inc Magenta Therapeutics, Inc. Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.97 - $3.08 $579,678 - $1.84 Million	-597,607 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$2.55 - $5.23 $2,368 - $4,858	929 Added 0.16%	597,607 $1.73 Million
Q4 2021 Feb 09, 2022	BUY	$4.43 - $8.33 $506,247 - $951,927	114,277 Added 23.69%	596,678 $2.64 Million
Q3 2021 Nov 09, 2021	BUY	$6.07 - $9.89 $45,531 - $74,184	7,501 Added 1.58%	482,401 $3.51 Million
Q2 2021 Aug 10, 2021	BUY	$9.76 - $14.15 $1.79 Million - $2.6 Million	183,700 Added 63.08%	474,900 $4.64 Million
Q1 2021 May 10, 2021	BUY	$7.66 - $13.38 $286,484 - $500,412	37,400 Added 14.74%	291,200 $3.45 Million
Q4 2020 Feb 08, 2021	BUY	$6.1 - $7.94 $89,060 - $115,924	14,600 Added 6.1%	253,800 $1.99 Million
Q3 2020 Nov 06, 2020	BUY	$6.52 - $8.94 $49,552 - $67,944	7,600 Added 3.28%	239,200 $1.63 Million
Q2 2020 Aug 05, 2020	BUY	$6.18 - $10.76 $3,708 - $6,456	600 Added 0.26%	231,600 $1.74 Million
Q4 2019 Feb 05, 2020	SELL	$9.07 - $15.84 $2,321 - $4,055	-256 Reduced 0.11%	231,000 $3.5 Million
Q3 2019 Nov 13, 2019	SELL	$9.63 - $14.0 $20,646 - $30,016	-2,144 Reduced 0.92%	231,256 $2.37 Million
Q2 2019 Aug 12, 2019	SELL	$13.4 - $17.67 $30,820 - $40,641	-2,300 Reduced 0.98%	233,400 $3.44 Million
Q1 2019 May 10, 2019	SELL	$5.7 - $19.7 $195,510 - $675,710	-34,300 Reduced 12.7%	235,700 $3.88 Million
Q4 2018 Feb 14, 2019	SELL	$5.57 - $11.65 $785,676 - $1.64 Million	-141,055 Reduced 34.32%	270,000 $1.54 Million
Q3 2018 Nov 14, 2018	BUY	$11.32 - $15.7 $13,708 - $19,012	1,211 Added 0.3%	411,055 $4.94 Million
Q2 2018 Aug 13, 2018	BUY	$13.5 - $14.52 $5.53 Million - $5.95 Million	409,844 New	409,844 $0

Others Institutions Holding MGTA

# of Institutions

Shares Held

442K

Call Options Held

Put Options Held

Hellman Jordan Management CO Inc Quincy, MA

441K
Shares

$0
0.3% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.3K
Shares

$0
0.0% of portfolio

View Full List

About Magenta Therapeutics, Inc.

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

More about MGTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account